A strange, contagious cancer is threatening Tasmanian devils, but researchers’ fight is fueling breakthroughs in science, ...
GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...
Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...
Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in ...
Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia December 11, 2025 10:00 AM ESTCompany ...
Zacks Small Cap Research on MSN
MTVA: New date for Vanoglipel (DA-1241) presented at AASLD…
MTVA READ THE FULL MTVA RESEARCH REPORT Business Update New Data from Phase 2a Trial of Vanoglipel (DA-1241) Presented at The Liver Meeting 2025 In November 2025, MetaVia, Inc. (NASDAQ:MTVA) announced ...
Morning Overview on MSN
GLP-1 drugs fail to slow Alzheimer’s in 2 major trials
Two of the most closely watched Alzheimer clinical trials of the decade have delivered a sobering verdict: GLP-1 drugs that ...
STEM-engineered CAR T cells performed as well as or better against cancer cells than did FDA-approved CAR T cells and kept their cancer-fighting abilities for longer.
Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in ...
A single signaling pathway controls whether immune cells attack or befriend cells they encounter while patrolling our bodies, ...
Microtubules perform an active role in communication within the cell by transmitting received signals to the cell's ...
Mapping how Narcan reverses opioid overdose can provide a molecular blueprint for developing more effective drugs against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback